Apoorva Mandavilli is a reporter for The New York Times, focusing on science and global health. She is the 2019 winner of the Victor Cohn Prize for Excellence in Medical Science Reporting.
This was featured in live coverage.
By Apoorva Mandavilli
The C.D.C. said on Thursday that Americans could choose a booster dose of a vaccine different from the one they had initially received.
Recipients of the Moderna and the J.&J. vaccines may receive extra doses. The agency also embraced a “mix-and-match” strategy.
Recipients of the Moderna and the J.&J. vaccines may receive extra doses, although the shots continue to prevent illness and death.
The finding upends conventional wisdom regarding coughing, long thought to be the main route of transmission.
Those eligible for the extra shot would include adults over 65 and others at high risk — the same groups now eligible for a Pfizer-BioNTech boost
By Sharon LaFraniere and Noah Weiland
The trend confirmed warnings that the coronavirus pandemic would undermine progress against other infectious diseases around the world.
La inmunidad natural varía de un paciente a otro, según afirman los científicos. Por eso es que la vacuna sigue siendo la mejor opción después de recuperarse de la enfermedad.
So-called natural immunity varies from patient to patient, scientists say. Immunization is still the best choice after recovering from the disease.